The antimicrobial potential of the secretome from Wharton’s jelly mesenchymal stem cells in the context of regenerative medicine: an in vitro study - Takeaways - MDSpire

The antimicrobial potential of the secretome from Wharton’s jelly mesenchymal stem cells in the context of regenerative medicine: an in vitro study

  • By

  • Filomena Napolitano

  • Emanuela Roscetto

  • Maria Fabozzi

  • Martina Aversa

  • Pietro Formisano

  • Maria Rosaria Catania

  • Nunzia Montuori

  • May 5, 2026

  • 0 min

Share

  • 1

    Wharton’s jelly mesenchymal stem cell secretome (WJ-MSC-CM) shows promise as a cell-free strategy in regenerative medicine.

  • 2

    WJ-MSC-CM exhibits antimicrobial properties, including significant inhibitory activity against Staphylococcus aureus.

  • 3

    WJ-MSC-CM enhances antioxidant responses in dermal fibroblasts exposed to hydrogen peroxide, protecting against cytotoxicity.

  • 4

    The secretome contains various bioactive molecules that promote wound healing and tissue repair.

  • 5

    Research indicates that WJ-MSCs may outperform other MSC sources in regulating inflammation and promoting cellular regeneration.

Original Source(s)

The antimicrobial potential of the secretome from Wharton’s jelly mesenchymal stem cells in the context of regenerative medicine: an in vitro study

  • by Filomena Napolitano, Emanuela Roscetto, Maria Fabozzi, Martina Aversa, Pietro Formisano, Maria Rosaria Catania, Nunzia Montuori

  • May 5, 2026

Related Content

Advancements and Uses of Infrared Thermography for Patients with Intestinal Stomas: A Scoping Review

Systematic review: The management of unhealed wounds and persistent perineal sinuses following proctectomy in inflammatory bowel disease

A mapping review of sacrococcygeal pilonidal sinus disease